1. Home
  2. VERU vs ZDGE Comparison

VERU vs ZDGE Comparison

Compare VERU & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.62

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Logo Zedge Inc. Class B

ZDGE

Zedge Inc. Class B

HOLD

Current Price

$3.06

Market Cap

41.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
ZDGE
Founded
1971
2008
Country
United States
United States
Employees
N/A
55
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
41.5M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
VERU
ZDGE
Price
$2.62
$3.06
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
65.5K
55.0K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
2.08%
EPS Growth
N/A
73.85
EPS
N/A
0.06
Revenue
$16,296,958.00
$29,398,000.00
Revenue This Year
N/A
$3.27
Revenue Next Year
N/A
$5.76
P/E Ratio
N/A
$51.67
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.73
52 Week High
$4.59
$4.70

Technical Indicators

Market Signals
Indicator
VERU
ZDGE
Relative Strength Index (RSI) 55.32 48.85
Support Level $2.15 $2.94
Resistance Level $2.77 $3.44
Average True Range (ATR) 0.16 0.20
MACD 0.02 -0.00
Stochastic Oscillator 79.17 47.06

Price Performance

Historical Comparison
VERU
ZDGE

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About ZDGE Zedge Inc. Class B

Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.

Share on Social Networks: